Vericel (VCEL) Misses Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- AMD shares fall amid AI chip sector selloff
- Alphabet shares drop ahead of earnings next week
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Vericel Corporation (VCEL) PT Lowered to $45 at BTIG
February 24, 2022 12:54 PM ESTBTIG analyst Ryan Zimmerman lowered the price target on Vericel Corporation (NASDAQ: VCEL) to $45.00 (from $50.00) while maintaining a Buy rating.
The analyst commented, "We maintain our Buy rating but lower our PT to $45 (from $50) as multiples have compressed in high-growth MedTech. VCEL reported 4Q21 revenue of $47.6M (+5.2% Y/Y) which was below BTIG/Consensus original expectations of $50.7M/$51.0M with the... More



